These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38778606)

  • 1. LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression.
    Gao D; Guo H; Liu Z; Bao L; Li S; Wang Y; Qiu J; Jiang B; Dang X
    Curr Cancer Drug Targets; 2024 May; ():. PubMed ID: 38778606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma.
    Yang Y; Gao L; Chen J; Xiao W; Liu R; Kan H
    Bioengineered; 2022 Apr; 13(4):9211-9231. PubMed ID: 35436411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma.
    Chen Y; Chen J; Shi Y; Ling X; Fang S; Zhong C; Liu F; Zhong W; Bi X; Dong Z; Lu J
    Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38224097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lamin B1 regulates the growth of hepatocellular carcinoma cells by influencing telomerase activity].
    Wang R; Chen S; Sun Z; Wang S; Wang J; Qin L; Li J
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1609-1620. PubMed ID: 37154326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway.
    Li W; Li X; Li X; Li M; Yang P; Wang X; Li L; Yang B
    Onco Targets Ther; 2020; 13():3129-3139. PubMed ID: 32346296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
    Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
    Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
    Yang Y; Xiao W; Liu R; Gao L; Chen J; Kan H
    J Immunol Res; 2022; 2022():4983532. PubMed ID: 36405011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma.
    Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G
    Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis].
    Wang GN; Zhang YP; Wang MC; Han W; Zhang YC
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095
    [No Abstract]   [Full Text] [Related]  

  • 10. RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma.
    Rao B; Li J; Ren T; Yang J; Zhang G; Liu L; Wang H; Huang M; Ren Z; Yu Z
    Front Cell Dev Biol; 2021; 9():686547. PubMed ID: 34350180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach.
    Fei X; Liu S; Liu P; Wang X; Zhu C; Hou J; Cai J; Pan Y
    Front Oncol; 2022; 12():1043161. PubMed ID: 36439418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LMNB1 deletion in ovarian cancer inhibits the proliferation and metastasis of tumor cells through PI3K/Akt pathway.
    Dong J; Ru Y; Zhai L; Gao Y; Guo X; Chen B; Lv X
    Exp Cell Res; 2023 May; 426(2):113573. PubMed ID: 37003558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma.
    Cui F; Wang W; Zhuang C; He D; Wang P
    Transl Cancer Res; 2024 Apr; 13(4):1606-1622. PubMed ID: 38737697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest.
    Wang X; Yang J; Luo L; Li X; Zhang Y
    Aging (Albany NY); 2023 May; 15(10):4122-4143. PubMed ID: 37211383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
    Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B
    Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated
    Cheng Q; Wang W; Liu J; Lv Z; Ji W; Yu J; Zhang W; Yang Y
    Front Immunol; 2023; 14():1173848. PubMed ID: 37207207
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
    Front Oncol; 2021; 11():713017. PubMed ID: 34595113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.
    Ren Y; Qian Y; Zhang Q; Li X; Li M; Li W; Yang P; Ren H; Li H; Weng Y; Li D; Xu K; Yu W
    Cancer Cell Int; 2024 Apr; 24(1):142. PubMed ID: 38643145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma.
    Lin J; Yan J; Deng XL; Wang CS; Wang HS
    BMC Gastroenterol; 2023 Jan; 23(1):8. PubMed ID: 36631750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.